Skip to Main Content

Paper Details

Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial.
JACC Basic Transl Sci
23
2021
Author NameAffiliation
David N HagerJohns Hopkins University School of Medicine
  • 1 - 1

Datasets

Release 1.2